OLD Category: pan cancer panels

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

• Kieran MW et al.,

Silencing of maternal hepatic glucocorticoid receptor is essential for normal fetal development in mice

• Quinn M.A. et. al.,

Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells

• Simon N et al.,

Phase I clinical trial of decitabine (5-aza-2′-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases

• Jansen Y.J.L. et. al.,

Nontuberculous mycobacterium M. avium infection predisposes aged mice to cardiac abnormalities and inflammation

• Headley C.A. et. al.,

High multiplex, digital spatial profiling of proteins and RNA in fixed tissue using genomic detection methods

• Merritt C.R. et. al.

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma

• Neuzillet C et al.,

Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium

• Kobayashi T. et al.,

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment

• Dillon M.T. et. al.,

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

• Cloughesy TF et al.,

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response

• Foster J.B. et. al.,

The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial

• Barroso-Sousa R. et. al.,